Pfizer filed the patent infringement case in the US District Court for the Southern District of New York on October 29. Actavis, Amneal Pharmaceuticals, Apotex and Mylan—all generic drug companies operating in the US—were named as defendants in the complaint.
The rest of this article is locked for subscribers only. Please login to continue reading.
If you don't have a login, you will need to purchase a subscription to gain access to this article, including all our online content. Please use this link and follow the steps.
For multi-user price options, or to check if your company has an existing subscription to us that we can add you to for FREE, please email Atif Choudhury at achoudhury@worldipreview.com
Pfizer, Viagra, generic rivals
